Metronidazole validates drugs targeting hypoxic bacteria for improved treatment of tuberculosis
Proc Natl Acad Sci U S A
.
2012 Aug 28;109(35):13890-1.
doi: 10.1073/pnas.1211081109.
Epub 2012 Aug 15.
Author
Ying Zhang
1
Affiliation
1
Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. yzhang@jhsph.edu
PMID:
22895789
PMCID:
PMC3435169
DOI:
10.1073/pnas.1211081109
No abstract available
Publication types
Comment
MeSH terms
Animals
Latent Tuberculosis / drug therapy*
Metronidazole / pharmacology*
Mycobacterium tuberculosis / drug effects*
Tuberculosis, Pulmonary / drug therapy*
Substances
Metronidazole